How has the rapid scale up of malaria control in Africa impacted vector competence?
This project aims to investigate the effects of insecticide use and drug resistance on malaria parasite development in mosquitoes to enhance vector control strategies and improve intervention options.
Projectdetails
Introduction
The malaria parasite Plasmodium falciparum is responsible for more than 200 million cases and 400,000 deaths each year, with over 90% of cases occurring in Africa. The parasite is reliant upon Anopheline mosquitoes for transmission, and insecticide-treated bed nets targeting these mosquitoes represent the single most efficacious way to reduce case numbers and hence deaths.
Insecticide Resistance
However, due to the use of pyrethroid insecticides on all distributed insecticide-treated bed nets, insecticide resistance now threatens the impact of these interventions. Analogously, deaths from active malaria cases have been decreasing through the successful use of drug therapy; however, resistance to every class of front-line drug has now been described.
Knowledge Gaps
Incredibly, we simply do not know the impact of current vector control tools on parasite development nor the impact of drug resistance on development within the mosquito vector, despite fine-scale characterization in the erythrocytic stages. With the stalling of progress in malaria elimination and the addition of new chemistries to insecticide-treated bed nets, it is time that we invested in understanding precisely how our current vector control tools affect the parasite in order to avoid catastrophic failure of malaria control.
Proposed Research
To this end, I propose to:
- Determine the impact of insecticide use on parasite development in the contexts of species replacement, insecticide resistance, and insecticide exposure.
- Elucidate the changes due to parasite drug resistance on mosquito-stage development.
- Ascertain genetic interplay between mosquito immunity and response to insecticides to identify new targets that negatively affect insecticide resistance and parasite development.
Expected Outcomes
The results generated from this multidisciplinary proposal will redefine our understanding of factors determining vector competence under contemporary transmission settings and will identify alternative options for intervention.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.499.581 |
Totale projectbegroting | € 1.499.581 |
Tijdlijn
Startdatum | 1-5-2023 |
Einddatum | 30-4-2028 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- UNIVERSITATSKLINIKUM HEIDELBERGpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
The malaria chemical atlas: Revealing the parasite-host functional interactomeThe MalChemAtlas project aims to uncover the chemical communication of the malaria parasite Plasmodium falciparum to develop novel interventions against malaria. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Mechanisms of dormancy, activation and sexual conversion in pre-erythrocytic malaria parasitesThe DEXES project aims to uncover the molecular mechanisms of Plasmodium liver infection outcomes influenced by host metabolism to inform new malaria treatment strategies. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Plasmodium liver stage schizogony: high replication and genetic diversityThis project aims to uncover the mechanisms behind Plasmodium's high replication rate during liver infection, linking it to genetic diversity and malaria severity to inform new intervention strategies. | ERC Advanced... | € 2.467.196 | 2023 | Details |
The role of an expanded family of exported effector kinases in environmental sensing and regulation of virulence in human malaria.This project aims to investigate the role of FIKK kinases in regulating cytoadhesion and rigidity of Plasmodium falciparum-infected red blood cells to understand malaria pathogenesis. | ERC Consolid... | € 1.999.935 | 2023 | Details |
The unusual role of a highly divergent Arp2/3 complex in the mosquito stages of malaria parasites.This project aims to elucidate the role of a Plasmodium-specific Arp2/3 complex in mosquito development to identify new antimalarial strategies targeting malaria transmission. | ERC Starting... | € 1.499.527 | 2025 | Details |
The malaria chemical atlas: Revealing the parasite-host functional interactome
The MalChemAtlas project aims to uncover the chemical communication of the malaria parasite Plasmodium falciparum to develop novel interventions against malaria.
Mechanisms of dormancy, activation and sexual conversion in pre-erythrocytic malaria parasites
The DEXES project aims to uncover the molecular mechanisms of Plasmodium liver infection outcomes influenced by host metabolism to inform new malaria treatment strategies.
Plasmodium liver stage schizogony: high replication and genetic diversity
This project aims to uncover the mechanisms behind Plasmodium's high replication rate during liver infection, linking it to genetic diversity and malaria severity to inform new intervention strategies.
The role of an expanded family of exported effector kinases in environmental sensing and regulation of virulence in human malaria.
This project aims to investigate the role of FIKK kinases in regulating cytoadhesion and rigidity of Plasmodium falciparum-infected red blood cells to understand malaria pathogenesis.
The unusual role of a highly divergent Arp2/3 complex in the mosquito stages of malaria parasites.
This project aims to elucidate the role of a Plasmodium-specific Arp2/3 complex in mosquito development to identify new antimalarial strategies targeting malaria transmission.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Mosquito-specific phagostimulants and pheromones for environment-friendly mosquito vector controlMolecular Attraction aims to evaluate the efficacy and environmental impact of innovative mosquito-specific semiochemicals in sub-Saharan Africa to enhance vector control and reduce disease burden. | EIC Accelerator | € 2.500.000 | 2023 | Details |
THERAPRODit project richt zich op het ontwikkelen van een behandeling voor West-Nile- en Chikungunya-virusinfecties door innovatieve screening van stoffen, om de virusvermenigvuldiging te stoppen. | Mkb-innovati... | € 163.275 | 2019 | Details |
Aanpak van Malaria met actieve componenten uit kruidenDit project onderzoekt traditionele Chinese kruidengeneeskunde om nieuwe, effectieve insecticiden tegen malaria-muggen te identificeren en de resistentie te overwinnen. | Mkb-innovati... | € 20.000 | 2022 | Details |
Vector Control CapsulesHet project richt zich op het bestrijden van de Aedes aegypti mug om de verspreiding van virussen zoals dengue en Zika te verminderen en zo de wereldwijde gezondheidsrisico's te verlagen. | Mkb-innovati... | € 185.003 | 2017 | Details |
Mobile Bio-Lab to support first response in Arbovirus outbreaksMOBVEC aims to develop the first VBD Mobile Bio-Lab to provide real-time vector surveillance and disease modeling, enhancing outbreak response and saving lives and healthcare costs. | EIC Pathfinder | € 2.998.500 | 2023 | Details |
Mosquito-specific phagostimulants and pheromones for environment-friendly mosquito vector control
Molecular Attraction aims to evaluate the efficacy and environmental impact of innovative mosquito-specific semiochemicals in sub-Saharan Africa to enhance vector control and reduce disease burden.
THERAPRO
Dit project richt zich op het ontwikkelen van een behandeling voor West-Nile- en Chikungunya-virusinfecties door innovatieve screening van stoffen, om de virusvermenigvuldiging te stoppen.
Aanpak van Malaria met actieve componenten uit kruiden
Dit project onderzoekt traditionele Chinese kruidengeneeskunde om nieuwe, effectieve insecticiden tegen malaria-muggen te identificeren en de resistentie te overwinnen.
Vector Control Capsules
Het project richt zich op het bestrijden van de Aedes aegypti mug om de verspreiding van virussen zoals dengue en Zika te verminderen en zo de wereldwijde gezondheidsrisico's te verlagen.
Mobile Bio-Lab to support first response in Arbovirus outbreaks
MOBVEC aims to develop the first VBD Mobile Bio-Lab to provide real-time vector surveillance and disease modeling, enhancing outbreak response and saving lives and healthcare costs.